- Home
- HOFT vs ANTX Comparison
HOFT vs ANTX Comparison
Compare HOFT & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | ANTX |
|---|---|---|
| Founded | 1924 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.6M | 170.7M |
| IPO Year | 1999 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HOFT | ANTX |
|---|---|---|
| Price | $15.40 | $4.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 110.8K | ★ 397.6K |
| Earning Date | 04-16-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | N/A | ★ 32.56 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $278,139,000.00 | N/A |
| Revenue This Year | $17.37 | N/A |
| Revenue Next Year | $9.00 | N/A |
| P/E Ratio | $155.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.62 | $1.00 |
| 52 Week High | $18.09 | $6.91 |
Technical Indicators
Market Signals| Indicator | HOFT | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 44.24 |
| Support Level | $15.08 | $3.82 |
| Resistance Level | $15.97 | $5.21 |
| Average True Range (ATR) | 1.04 | 0.38 |
| MACD | -0.23 | -0.09 |
| Stochastic Oscillator | 7.50 | 20.42 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.